# Acumen Pharmaceuticals, Inc.: Form 8-K, filed Mar 16, 2026

- Company: [Acumen Pharmaceuticals, Inc.](/companies/abos.md) (CIK 1576885)
- Form: 8-K
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 07:01 ET
- Period: 2026-03-13
- Accession: 0001628280-26-017885
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1576885/000162828026017885/abos-20260313.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1576885/000162828026017885/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1576885/000162828026017885/abos-20260313.htm

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-017885. Last ingested by Listed: Oct 30, 2026, 07:07 ET. No prices; not investment advice.